Study to Evaluate the Efficacy of Adalimumab in Patients With Erosive Osteoarthritis of the Interphalangeal Finger Joints

• Status: Completed
• Trial end date: 2009-02-01
• Target enrollment: 0
• Participant gender: All

Summary

Patients will be randomized into two groups (1/1) during one year:

• 40 mg adalimumab subcutaneously (sc) every other week

• placebo

The effect on x-rays and clinical parameters will be evaluated.

• Phase: Phase 2
• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: University Hospital, Ghent
• Treatments: Adalimumab

Criteria

Inclusion Criteria:

• Clear erosive image on x-ray of at least one interphalangeal finger joint